CTN :42676801
19 Dec, 2025
NA
Tender For corrigendum : entering rate contract for supply of medicines and drugs to the health institutions in ut of puducherry - before quoting bidders were requested to check the schedule of requirement in the notice inviting tender for supply units and estimated annual requirement. the selected bidder shall supply the items as per the supply units mentioned in the nit. note: for all the items samples should be submitted. without sample quotation will be rejected., acetic acid 2% w/v otic solution (ear drops), bimaroprost ophthalmic solution 0.01%, chloramphenical ear drops (5% w/v), eugenol liquid, gentamycin 0.3%w/v with dexamethasone 0.1%w/v eye drops, glucose glycerol nasal drops, pilocarpine nitrate eye drops (2% w/v), sodium citrate eye drops 10%, sodium citrate eye drops 10% w/v, tacrolimus eye drops 0.02% w/v, 5-fluorouracil injection 50 mg/ml, amikacin injection 125 mg/ml, aminophylline injection 25mg/ml, amphotericin b injection 50 mg, antihuman thymocyte immunoglobulin (rabbit) injection 5mg/ml, basiliximab injection injection 20mg, benzyl penicillin injection (600 mg) 10 lac iu, beractant intratracheal suspension (25mg/ml ), carbetocin injection 100 mcg/ml, chlorpromazine hydrochloride injection 25 mg/ml, c-tb injection 0.1 g/0.1 ml, dalteparin sodium injection 5000 iu/0.2 ml, diltiazem hydrochloride injection 5 mg/ml, doxylamine succinate + pyridoxine hydrochloride injection, fluconazole infusion 2 mg/ml injection, fluorescein sodium injection 10% w/v, fluorescein sodium injection 20% w/v, glucagon hydrochloride injection 1mg, glyceryl trinitrate injection 1 mg/ml, class="text-red-selected">hepatitis b immunoglobulin 100 iu/0.5 ml,
class="text-red-sele
cted">hepatitis b va
ccine (geneti
cally engineered) 0.5 ml, human albumin inje
ction 4.5%, human rabies immunoglobulin inje
ction 300 iu, insulin aspart inje
ction 100units / ml, insulin detemir inje
ction 100units/ml, insulin glargine inje
ction 100units/ml, insulin-biphasi
c isophane insulin inje
ction i.p. (30% soluble insulin & 70% isophane insulin) 40 iu/ml, insulin-biphasi
c isophane insulin inje
ction i.p. (50% soluble insulin & 50% isophane insulin) 40 iu/ml, insulin-isophane insulin inje
ction (intermediate a
cting) 40 iu/ml, insulin-soluble insulin inje
ction (rapid or short a
cting, neutral solution) 40 iu/ml, iron dextran inje
ction 50 mg/ml, isoxsuprine hydro
chloride inje
ction 5 mg/ml, ketamine hydro
chloride inje
ction 10 mg/ml, ketamine hydro
chloride inje
ction 50 mg/ml, levofloxa
cin inje
ction 500 mg/20 ml, ligno
caine hydro
chloride 21.3 mg/ml with sodium
chloride 6 mg/ml inje
ction (i.v.) (preservative free ), lorazepam inje
ction 2 mg/ml, methotrexate sodium inje
ction 25 mg/ml, methyldopa inje
ction 50 mg/ml, methylene blue inje
ction 10mg/ml, metoprolol tartrate inje
ction ip 1 mg/ml, mitomy
cin
c inje
ction 2mg, mono
clonal purified antihemophili
c fa
ctor viii (human) inje
ction 1000 iu, mono
clonal purified antihemophili
c fa
ctor viii (human) inje
ction 250 iu, mono
clonal purified antihemophili
c fa
ctor viii (human) inje
ction 500 iu, ni
corandil inje
ction 48 mg, phenobarbitone sodium inje
ction 200 mg/ml, pheno
caine intra
cameral preservative free inje
ction, pilo
carpine nitrate intra
cameral preservative free inje
ction, pla
centa extra
ct inje
ction, pneumo
co
ccal polysa
ccharide va
ccine (23 valent) 0.5 ml, polido
canol 3% inje
ction, pro
chlorperazine mesylate inje
ction 12.5mg / ml, rabies human mono
clonal antibody inje
ction 50 iu/1.25 ml, re
combinant granulo
cyte mono
cyte-
colony stimulating fa
ctor (gm-
csf) 500ug, re
combinant human growth hormone inje
ction 0.45 mg/ml, remdesivir inje
ction 100 mg, sodium 2-mer
captoethanesulphonate inje
ction 100 mg/ml, sodium tetrade
cyl suphate 3% inje
ction, streptomy
cin inje
ction 0.75 g, terbutaline inje
ction 0.25 mg, tuber
culin, purified protein derivative diluted 1 tu/0.1 ml, urokinase inje
ction 5 la
c iu, verapamil hydro
chloride inje
ction 2.5 mg/ml, vitamin a inje
ction 100,000 iu, zoledrani
c a
cid inje
ction 5mg/100ml, atropine sulphate 0.5mg/ml ivf, haemo dialysis fluid (a
cetate solution), haemo dialysis flui